Selected research
Industry Research
Icatibant Acetate Industry Research Report 2026
Market perspective
The global Icatibant Acetate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Icatibant Acetate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Icatibant Acetate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Icatibant Acetate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Icatibant Acetate include AmbioPharm, BCN Peptides SA, Cheiron Pharma, ChemWerth, Henberg Chemie, Midas Pharma, Toronto Research Chemicals, Chengdu Shengnuo Biopharm and Hansoh Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Icatibant Acetate market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Icatibant Acetate Market by Company
AmbioPharm
BCN Peptides SA
Cheiron Pharma
ChemWerth
Henberg Chemie
Midas Pharma
Toronto Research Chemicals
Chengdu Shengnuo Biopharm
Hansoh Pharma
Hubei Jianxiang Biopharmaceuticals
Icatibant Acetate Segment by Type
Purity ≥99%
Purity ≥98%
Icatibant Acetate Segment by Application
Online Sales
Offline Sales
Icatibant Acetate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icatibant Acetate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Icatibant Acetate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icatibant Acetate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Icatibant Acetate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Icatibant Acetate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Icatibant Acetate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥99%
- Purity ≥98%
Applications
- Online Sales
- Offline Sales
Companies covered
- AmbioPharm
- BCN Peptides SA
- Cheiron Pharma
- ChemWerth
- Henberg Chemie
- Midas Pharma
- Toronto Research Chemicals
- Chengdu Shengnuo Biopharm
- Hansoh Pharma
- Hubei Jianxiang Biopharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Icatibant Acetate Market Size (2021-2032)
- 2.2.2 Global Icatibant Acetate Sales (2021-2032)
- 2.2.3 Global Icatibant Acetate Market Average Price (2021-2032)
- 2.3 Icatibant Acetate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity ≥99%
- 2.3.3 Purity ≥98%
- 2.4 Icatibant Acetate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Icatibant Acetate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Icatibant Acetate Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Icatibant Acetate Revenue of Manufacturers (2021-2026)
- 3.4 Global Icatibant Acetate Average Price by Manufacturers (2021-2026)
- 3.5 Global Icatibant Acetate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Icatibant Acetate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Icatibant Acetate, Product Type & Application
- 3.8 Global Manufacturers of Icatibant Acetate, Established Date
- 3.9 Global Icatibant Acetate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AmbioPharm
- 4.1.1 AmbioPharm Company Information
- 4.1.2 AmbioPharm Business Overview
- 4.1.3 AmbioPharm Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AmbioPharm Icatibant Acetate Product Portfolio
- 4.1.5 AmbioPharm Recent Developments
- 4.2 BCN Peptides SA
- 4.2.1 BCN Peptides SA Company Information
- 4.2.2 BCN Peptides SA Business Overview
- 4.2.3 BCN Peptides SA Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BCN Peptides SA Icatibant Acetate Product Portfolio
- 4.2.5 BCN Peptides SA Recent Developments
- 4.3 Cheiron Pharma
- 4.3.1 Cheiron Pharma Company Information
- 4.3.2 Cheiron Pharma Business Overview
- 4.3.3 Cheiron Pharma Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cheiron Pharma Icatibant Acetate Product Portfolio
- 4.3.5 Cheiron Pharma Recent Developments
- 4.4 ChemWerth
- 4.4.1 ChemWerth Company Information
- 4.4.2 ChemWerth Business Overview
- 4.4.3 ChemWerth Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ChemWerth Icatibant Acetate Product Portfolio
- 4.4.5 ChemWerth Recent Developments
- 4.5 Henberg Chemie
- 4.5.1 Henberg Chemie Company Information
- 4.5.2 Henberg Chemie Business Overview
- 4.5.3 Henberg Chemie Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Henberg Chemie Icatibant Acetate Product Portfolio
- 4.5.5 Henberg Chemie Recent Developments
- 4.6 Midas Pharma
- 4.6.1 Midas Pharma Company Information
- 4.6.2 Midas Pharma Business Overview
- 4.6.3 Midas Pharma Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Midas Pharma Icatibant Acetate Product Portfolio
- 4.6.5 Midas Pharma Recent Developments
- 4.7 Toronto Research Chemicals
- 4.7.1 Toronto Research Chemicals Company Information
- 4.7.2 Toronto Research Chemicals Business Overview
- 4.7.3 Toronto Research Chemicals Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Toronto Research Chemicals Icatibant Acetate Product Portfolio
- 4.7.5 Toronto Research Chemicals Recent Developments
- 4.8 Chengdu Shengnuo Biopharm
- 4.8.1 Chengdu Shengnuo Biopharm Company Information
- 4.8.2 Chengdu Shengnuo Biopharm Business Overview
- 4.8.3 Chengdu Shengnuo Biopharm Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chengdu Shengnuo Biopharm Icatibant Acetate Product Portfolio
- 4.8.5 Chengdu Shengnuo Biopharm Recent Developments
- 4.9 Hansoh Pharma
- 4.9.1 Hansoh Pharma Company Information
- 4.9.2 Hansoh Pharma Business Overview
- 4.9.3 Hansoh Pharma Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hansoh Pharma Icatibant Acetate Product Portfolio
- 4.9.5 Hansoh Pharma Recent Developments
- 4.10 Hubei Jianxiang Biopharmaceuticals
- 4.10.1 Hubei Jianxiang Biopharmaceuticals Company Information
- 4.10.2 Hubei Jianxiang Biopharmaceuticals Business Overview
- 4.10.3 Hubei Jianxiang Biopharmaceuticals Icatibant Acetate Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hubei Jianxiang Biopharmaceuticals Icatibant Acetate Product Portfolio
- 4.10.5 Hubei Jianxiang Biopharmaceuticals Recent Developments
5 Global Icatibant Acetate Market Scenario by Region
- 5.1 Global Icatibant Acetate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Icatibant Acetate Sales by Region: 2021-2032
- 5.2.1 Global Icatibant Acetate Sales by Region: 2021-2026
- 5.2.2 Global Icatibant Acetate Sales by Region: 2027-2032
- 5.3 Global Icatibant Acetate Revenue by Region: 2021-2032
- 5.3.1 Global Icatibant Acetate Revenue by Region: 2021-2026
- 5.3.2 Global Icatibant Acetate Revenue by Region: 2027-2032
- 5.4 North America Icatibant Acetate Market Facts & Figures by Country
- 5.4.1 North America Icatibant Acetate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Icatibant Acetate Sales by Country (2021-2032)
- 5.4.3 North America Icatibant Acetate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Icatibant Acetate Market Facts & Figures by Country
- 5.5.1 Europe Icatibant Acetate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Icatibant Acetate Sales by Country (2021-2032)
- 5.5.3 Europe Icatibant Acetate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Icatibant Acetate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Icatibant Acetate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Icatibant Acetate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Icatibant Acetate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Icatibant Acetate Market Facts & Figures by Country
- 5.7.1 South America Icatibant Acetate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Icatibant Acetate Sales by Country (2021-2032)
- 5.7.3 South America Icatibant Acetate Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Icatibant Acetate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Icatibant Acetate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Icatibant Acetate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Icatibant Acetate Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Icatibant Acetate Sales by Type (2021-2032)
- 6.1.1 Global Icatibant Acetate Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Icatibant Acetate Sales Market Share by Type (2021-2032)
- 6.2 Global Icatibant Acetate Revenue by Type (2021-2032)
- 6.2.1 Global Icatibant Acetate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Icatibant Acetate Revenue Market Share by Type (2021-2032)
- 6.3 Global Icatibant Acetate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Icatibant Acetate Sales by Application (2021-2032)
- 7.1.1 Global Icatibant Acetate Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Icatibant Acetate Sales Market Share by Application (2021-2032)
- 7.2 Global Icatibant Acetate Revenue by Application (2021-2032)
- 7.2.1 Global Icatibant Acetate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Icatibant Acetate Revenue Market Share by Application (2021-2032)
- 7.3 Global Icatibant Acetate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Icatibant Acetate Value Chain Analysis
- 8.1.1 Icatibant Acetate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Icatibant Acetate Production Mode & Process
- 8.2 Icatibant Acetate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Icatibant Acetate Distributors
- 8.2.3 Icatibant Acetate Customers
9 Global Icatibant Acetate Analyzing Market Dynamics
- 9.1 Icatibant Acetate Industry Trends
- 9.2 Icatibant Acetate Industry Drivers
- 9.3 Icatibant Acetate Industry Opportunities and Challenges
- 9.4 Icatibant Acetate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst